Save
Effects of vorapaxar on clot characteristics, coagulation, inflammation, and platelet and endothelial function in patients treated with mono‐ and dual‐antiplatelet therapy
ISTH Academy, Paul A. Gurbel, 287580
Cross‐reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH‐AH 01/2010 Study
ISTH Academy, Andreas Tiede, 287581
The (non‐)sense of detecting anti‐cardiolipin and anti‐β2glycoprotein I IgM antibodies in the antiphospholipid syndrome
ISTH Academy, Katrien Devreese, 287582
Use of direct oral anticoagulants in antiphospholipid syndrome: Reply
ISTH Academy, fabretti veronique, 287583
Glycosylation sterically inhibits platelet adhesion to von Willebrand factor without altering intrinsic conformational dynamics
ISTH Academy, Matthew Auton, 287584
What the neighbors say
ISTH Academy, Faculty / Presenter(s), 287590
Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro
ISTH Academy, Chunyan Gao, 287591
A multicenter study of anticoagulation in operable chronic thromboembolic pulmonary hypertension
ISTH Academy, Mark Toshner, 287592
Screening pulmonary angiogram and the effect on anticoagulation strategies in severe respiratory failure patients on venovenous extracorporeal membrane oxygenation
ISTH Academy, Emma L. Hartley, 287593
A new WHO reference reagent for activated blood coagulation factor X (FXa), human (15/102)
ISTH Academy, Craig Thelwell, 287594
Inflammaging and platelet hyperreactivity: A new therapeutic target?
ISTH Academy, Paul Harrison, 287595
Role of thrombomodulin expression on hematopoietic stem cells
ISTH Academy, Hartmut Weiler, 287596
Issue Information
ISTH Academy, Faculty / Presenter(s), 287597
The 3.2 Å structure of a bioengineered variant of blood coagulation factor VIII indicates two conformations of the C2 domain
ISTH Academy, P. Clint Spiegel, 287598
Sex‐specific differences in chronic thromboembolic pulmonary hypertension. Results from the European CTEPH registry
ISTH Academy, P. Clint Spiegel, 287599
Human endothelial cells size‐select their secretory granules for exocytosis to modulate their functional output
ISTH Academy, Daniel Cutler, 287600
ISTH News and Updates: Join the ISTH Today – Student Membership is Now Free!
ISTH Academy, Faculty / Presenter(s), 287606
Changes
ISTH Academy, Faculty / Presenter(s), 287607
Novel inhibitor ZED3197 as potential drug candidate in anticoagulation targeting coagulation FXIIIa (F13a)
ISTH Academy, Ralf Pasternack, 287608
Professor Russell F. Doolittle (1931‐2019)
ISTH Academy, Faculty / Presenter(s), 287609
Venous thromboembolism in breast cancer patients receiving cyclin‐dependent kinase inhibitors
ISTH Academy, Alok Khorana, 287610
P2X1 ion channel deficiency causes massive bleeding in inflamed intestine and increases thrombosis
ISTH Academy, Cécile Oury, 287611
Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis
ISTH Academy, Cécile Oury, 287612
Mouse Models of Thrombosis
ISTH Academy, Beatrice Hechler & Brian Cooley, 286712
New insights into cancer's exploitation of platelets
ISTH Academy, Joseph Palumbo, 287041
Engineered microparticles and nanoparticles for fibrinolysis
ISTH Academy, Antonio Formentin, 287042
Does cardiorespiratory fitness really influence venous thromboembolism risk?
ISTH Academy, Setor K. Kunutsor, 287043
A synthetic heparin mimetic that allosterically inhibits factor XIa and reduces thrombosis in vivo without enhanced risk of bleeding
ISTH Academy, Umesh Desai, 287044
Platelet reactivity inhibition following ticagrelor loading dose in patients undergoing percutaneous coronary intervention for acute coronary syndrome
ISTH Academy, Vassili Panagides, 287045
Net‐clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more
ISTH Academy, Vassili Panagides, 287046
A Glanzmann thrombasthenia family associated with a TUBB1‐related macrothrombocytopenia
ISTH Academy, Alan Nurden, 287047
ISTH News and Updates: Join the ISTH Today
ISTH Academy, Faculty / Presenter(s), 287048
Platelet‐type von Willebrand disease: Local disorder of the platelet GPIbα β‐switch drives high‐affinity binding to von Willebrand factor
ISTH Academy, Matthew Auton, 287049
Risk factors for cancer‐associated venous thromboembolism: The venous thromboembolism prevention in the ambulatory cancer clinic (VTE‐PACC) study
ISTH Academy, Neil Zakai, 287050
The roles of factor Va and protein S in formation of the activated protein C/protein S/factor Va inactivation complex
ISTH Academy, Josefin Ahnstrom, 287051
Toward a better understanding of factor XI activation
ISTH Academy, Jonas Emsley, 287052
An anticoagulant that does not cause bleeding – an abrupt stop on the road to the Holy Grail
ISTH Academy, Joost C.M. Meijers, 287053
What the neighbors say
ISTH Academy, Faculty / Presenter(s), 287054
A single‐domain antibody that blocks factor VIIa activity in the absence but not presence of tissue factor
ISTH Academy, Cecile Denis, 287055
Heparin‐induced thrombocytopenia: An international assessment of the quality of laboratory testing
ISTH Academy, Rita Selby, 287056
Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis
ISTH Academy, Jeffrey I. Weitz, 287057
Identification of cysteine thiol‐based linkages in ADAMTS13 in support of a non‐proteolytic regulation of von Willebrand factor
ISTH Academy, Heinrich Vogt, 287058
Direct oral anticoagulant for the prevention of thrombosis in ambulatory patients with cancer: A systematic review and meta‐analysis
ISTH Academy, Gary H. Lyman, 287059
Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository
ISTH Academy, Maria Efthymiou, 287060
Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis
ISTH Academy, Gary H. Lyman, 287061
Nomenclature of factor XI and the contact system
ISTH Academy, Alvin Schmaier, 287062
Cardiorespiratory fitness and future risk of venous thromboembolism
ISTH Academy, Line H. Evensen, 287063
Issue Information
ISTH Academy, Faculty / Presenter(s), 287064
Activation of toll‐like receptors 2 and 4 on CD34 cells increases human megakaryo/thrombopoiesis induced by thrombopoietin
ISTH Academy, Mirta Schattner, 287065
Rivaroxaban does not affect growth of human pancreatic tumors in mice
ISTH Academy, Nigel Mackman, 287066
Hydrogen‐deuterium exchange mass spectrometry highlights conformational changes induced by factor XI activation and binding of factor IX to factor XIa
ISTH Academy, Joost C.M. Meijers, 287067
Polyphosphate, Zn and high molecular weight kininogen modulate individual reactions of the contact pathway of blood clotting
ISTH Academy, Tabish Armaan, 287068
Pediatric Thrombosis
ISTH Academy, Char Witmer & Heleen van Ommen, 286681
Cancer Associated Thrombosis
ISTH Academy, Faculty / Presenter(s), 286356
Module 2: Treatment of Cancer-Associated Thrombosis
ISTH Academy, Marc Carrier & Simon Noble, 286355
Module1 : Primary Thromboprophylaxis in Ambulatory Patients with Cancer
ISTH Academy, Alok Khorana & Tzu-Fei Wang, 286354
Pre-Test
ISTH Academy, Faculty / Presenter(s), 286353
Personal Information form - mandatory to receive CME
ISTH Academy, Faculty / Presenter(s), 286352
Extended treatment with edoxaban in cancer patients with venous thromboembolism: A post‐hoc analysis of the Hokusai‐VTE Cancer study
ISTH Academy, Marcello Di Nisio, 286267
Corrigendum
ISTH Academy, Faculty / Presenter(s), 286268
Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P‐selectin predict occult cancer after unprovoked venous thromboembolism
ISTH Academy, Fredrik Stangenberg, 286269
Elevated thrombin generation in patients with congenital disorder of glycosylation and combined coagulation factor deficiencies
ISTH Academy, Delphine Borgel, 286270
Prevalence of postpartum venous thromboembolism risk factors in an Irish urban obstetric population
ISTH Academy, , 286271
Utility of repeat testing in the evaluation for von Willebrand disease in pediatric patients
ISTH Academy, Bhavya Doshi, 286272
Scientific and Standardization Committee Communication: Guidance document on the periprocedural management of patients on chronic oral anticoagulant therapy: Recommendations for standardized reporting of procedural/surgical bleed risk and patient‐specific thromboembolic risk
ISTH Academy, , 286273
Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study
ISTH Academy, Borge Nordestgaard, 286274
Quality of life and functional limitations after pulmonary embolism and its prognostic relevance
ISTH Academy, Mareike Lankeit, 286275
What The Neighbors Say
ISTH Academy, Faculty / Presenter(s), 286276
Mechanisms of vascular permeability and remodeling associated with hemarthrosis in factor VIII‐deficient mice
ISTH Academy, Esther J. Cooke, 286277
Thrombin: Coagulation's master regulator of innate immunity
ISTH Academy, Edward Conway, 286278
Transgender patients and the role of the coagulation clinician
ISTH Academy, Mareike Lankeit, 286279
International Society on Thrombosis and Haemostasis core curriculum project: Core competencies in laboratory thrombosis and hemostasis
ISTH Academy, Karen Moffat, 286280
ISTH News and Updates: Join the ISTH Today
ISTH Academy, Faculty / Presenter(s), 286281
Glucose metabolism affects coagulation factors: The NEO study
ISTH Academy, Astrid Van Hylckama Vlieg, 286282
Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC
ISTH Academy, Bernard Tardy, 286283
A Genome Wide Association Study on plasma FV levels identified PLXDC2 as a new modifier of the coagulation process
ISTH Academy, Pierre-Emmanuel Morange, 286284
Ischemic limb necrosis in septic shock: What is the role of high‐dose vasopressor therapy?
ISTH Academy, Mareike Lankeit, 286285
Diagnosis and management of sepsis‐induced coagulopathy and disseminated intravascular coagulation
ISTH Academy, Toshiaki Iba, 286286
Issue Information
ISTH Academy, Faculty / Presenter(s), 286287
The risk of major bleeding in patients with suspected heparin‐induced thrombocytopenia
ISTH Academy, Allyson M. Pishko, 286288
Aquagenic pruritus in essential thrombocythemia is associated with a higher risk of thrombosis
ISTH Academy, Christelle Le Gall‐Ianotto, 286289
Defective fibrin deposition and thrombus stability in Bambi mice are mediated by elevated anticoagulant function
ISTH Academy, Isabelle Irene Salles-Crawley, 286290
Temporal map of the pig polytrauma plasma proteome with fluid resuscitation and intravenous vitamin C treatment
ISTH Academy, Ramesh Natarajan, 286291
Purification of silica‐free DNA and characterization of its role in coagulation
ISTH Academy, Paul Kim, 286292
Thrombophilia testing: What can be tested & What should be tested
ISTH Academy, Joost Meijers and Saskia Middeldorp, 273715
Recognizing Excellence in Peer Review
ISTH Academy, Faculty / Presenter(s), 286318
The risk of arterial thromboembolic events after cancer diagnosis
ISTH Academy, Babak B. Navi, 286319
Platelet preparation for function testing in the laboratory and clinic: Historical and practical aspects
ISTH Academy, Christian Gachet, 286320
Hemostatic complications associated with ventricular assist devices
ISTH Academy, Thomas Deloughery, 286321
Blood platelet research in autism spectrum disorders: In search of biomarkers
ISTH Academy, Kathleen Freson, 286322
Corrigendum
ISTH Academy, Faculty / Presenter(s), 286323
Pulmonary embolism response teams: Purpose, evidence for efficacy, and future research directions
ISTH Academy, Mateo Porres‐Aguilar, 286324
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
ISTH Academy, Pamela L. Lutsey, 286333
Alternative trafficking of Weibel‐Palade body proteins in CRISPR/Cas9‐engineered von Willebrand factor–deficient blood outgrowth endothelial cells
ISTH Academy, Ruben Bierings, 286334
Corrigendum
ISTH Academy, Faculty / Presenter(s), 286335
Blood platelets: Circulating mirrors of neurons?
ISTH Academy, Ilaria Canobbio, 286336
Post‐thrombotic syndrome in children: Measurement properties of CAPTSure, a new diagnostic tool
ISTH Academy, Maria Laura Avila, 286337
Erratum
ISTH Academy, Faculty / Presenter(s), 286338
Factor XII – What's important but not commonly thought about
ISTH Academy, Alvin Schmaier, 286339
Warfarin vs. apixaban in nonvalvular atrial fibrillation, and analysis by concomitant antiarrhythmic medication use: A national retrospective study
ISTH Academy, Matthew Wanat, 286340

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings